pharma · Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative Breast Cancer · Acute Myeloid Leukemia
Stemline Therapeutics (United
Stemline Therapeutics B.V.
Stemline Therapeutics (United clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- New York, USA
- Employees
- 767
- Programs
- 7
- Drugs
- 29
- Patents
- 0
Stemline Therapeutics (United projects
2 ClinicalTrials.gov programs sponsored by Stemline Therapeutics (United.
Stemline Therapeutics (United has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Stemline Therapeutics (United have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.